SCHEMBL2866652

SCHEMBL2866652

CS(=O)(=O)Nc1cc2c(-c3cc4ccccc4s3)n[nH]c2cc1F

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 4/20 0.47
MAPKAPK2 P49137 1/20 0.47
TRPV1 Q8NER1 1/20 0.44
MAPK10 P53779 1/20 0.42
ACLY P53396 5/20 0.41
MAP2K4 P45985 1/20 0.41
CKS1B P61024 1/20 0.39
SKP2 Q13309 1/20 0.39
ITK Q08881 2/20 0.37
NTRK1 P04629 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862092 0.83 MAPK10 (0.49) TNIKMAPKAPK2TRPV1MAPK10ITK
SCHEMBL2861026 0.81 TNIK (0.49) TNIKMAPKAPK2TRPV1MAPK10ACLY
SCHEMBL4329381 0.78 MAPK10 (0.59) MAPKAPK2MAPK10ITKNTRK1SIRT2
SCHEMBL2861529 0.78 MAPKAPK2 (0.53) MAPKAPK2MAPK10MAP2K4ITKSIRT2
SCHEMBL2863181 0.78 MAPKAPK2 (0.48) MAPKAPK2MAPK10MAP2K4ITKSIRT2
SCHEMBL2866702 0.77 MAPK10 (0.44) TNIKMAPKAPK2MAPK10ITKSIRT2
SCHEMBL2862999 0.76 MAPK10 (0.47) MAPKAPK2MAPK10ACLYMAP2K4SIRT2
SCHEMBL4337651 0.76 MAPK10 (0.46) MAPKAPK2MAPK10ITK
SCHEMBL2862889 0.76 TNIK (0.48) TNIKMAPKAPK2TRPV1MAPK10ACLY
SCHEMBL2859875 0.75 MAPKAPK2 (0.46) MAPKAPK2MAPK10ACLYMAP2K4ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 TNIK 1243/4885MAPKAPK2 18/4885TRPV1 510/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 TNIK 1274/4885MAPKAPK2 26/4885TRPV1 868/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 TNIK 1243/4885MAPKAPK2 18/4885TRPV1 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.